Director, Global Clinical Physician, Oncology

WeekdayDoc's proprietary algorithm rates Director, Global Clinical Physician, Oncology at Bristol Myers Squibb a 6.0 out of 10 for work-life balance — classified as good. This places the position in the top 35% of all Oncology physician listings evaluated on our platform. Contributing factors include no on-call duties, no weekend requirements, remote work flexibility.

This score reflects a generally positive work environment with some areas for improvement. Clinicians should evaluate scheduling and workload expectations carefully.

This Oncology position at Bristol Myers Squibb is open to physician candidates.

Physicians (MD/DO) are in high demand across healthcare settings, with growing interest in positions that offer sustainable schedules and reduced administrative burden.

Nationally, Oncology professionals earn a median annual salary of approximately $380k, with the typical range spanning $290k to $520k depending on experience, location, and practice setting.

Remote physician positions in Oncology have grown significantly in recent years, offering clinicians the ability to maintain a full patient panel without geographic constraints or commute-related burnout.

This is a fully remote physician position. Remote clinicians can practice from any state where they hold an active license, eliminating commute time and offering maximum schedule flexibility. Many remote healthcare positions also allow providers to establish a more sustainable long-term practice pattern.

Key skills and qualifications: Medical Monitoring, Clinical Trial Design, GCP Compliance, Protocol Development, Safety Management, Benefit/Risk Analysis, Stakeholder Engagement, Regulatory Writing. Candidates with experience in these areas may be especially well-suited for this Oncology role.

Core responsibilities: The role provides medical accountability and oversight for Phase 1-3 oncology clinical trials, focusing on protocol design and safety monitoring. It involves collaborating with cross-functional teams and engaging with health authorities and key opinion leaders.